Just Answers - News and Society

Some of the proposed solutions for global warming like capping-and-trading of carbon credits can actually be transferred

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

to other sectors and applied to other pressing social problems.

Take education in general, and illiteracy in particula

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

r, for example.

Why not create an artificial scarcity of illiteracy just like creating an artificial scarcity of carbon

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

dioxide emissions?

Just like both the private sector and the Congress are working in parallel tracks to determine a cap

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

on the kind of “carbon footprint” that private corporations can have without incurring any penalties, the Congress, pr

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

vate sector and the municipalities can also work on an artificial cap on the percentage of illiteracy that will be allow

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

ed in a city, county, state, or even corporation.

Different “certificates” or “permits” can be issued for different lev

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

els of “illiteracy.”

Then, the entities that are below their “illiteracy quotas” can sell their permits to those entiti

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

s that have too many illiterates. Hopefully the cost of buying such permits will be so prohibitive that the entity in qu

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

estion will soon see the benefit of marshaling all its resources to bring its illiteracy level to within the cap limits.

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

And what if an entity can neither afford such illiteracy credits nor pull its illiteracy to within the cap limits? You

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

obviously cannot "shut down" a city as though it were a corporation.

Perhaps Congress and state legislators can index s

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

uch compliance to withholding of various funds from the state or federal budget?

At some point this should have a posit

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

ve snowballing effect on those who comply fast with such illiteracy caps – not only they would make money by selling the

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

ir permits but also they would enhance the educational attainment of their workforce even further by channeling such new

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

funds again into their educational system. Thus I have to admit that this idea carries in its nucleus the danger of maki

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

ng the good even better while punishing the already disadvantaged even further – unless they do something about it.

Som

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

etimes such real and credible threats, on the one hand, and real and credible rewards, on the other, are exactly what is

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

needed to galvanized whole communities into some serious action and give them the necessary motivation to achieve what h

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

as until then been deemed “impossible.”

-------------------------------------------------------------------------------

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.justanswers.org.ua/article/190741/justanswers-Environment--CappingandTrading-Carbon-Credits--Why-Stop-There.html">Environment - Capping-and-Trading Carbon Credits - Why Stop There?</a>

BB link (for phorums):
[url=http://www.justanswers.org.ua/article/190741/justanswers-Environment--CappingandTrading-Carbon-Credits--Why-Stop-There.html]Environment - Capping-and-Trading Carbon Credits - Why Stop There?[/url]

There is a tendency of employees’ aging. The positive and negative influences of this trend will be discussed in the article. I will also talk about managerial tools that can be implemented in such case in order to increase business operation’s activities.

The internet market, thanks to the greater ease of access is surging ahead exponentially. So how is it a leveler? Web pages are presented in virtual space. The browser, or surfer, is not interested in where the company is based or how large it is, all of these are transparent to them. With a visually effective web page a small to medium company can compete with other larger companies.

If you have a mortgage and are not familiar with YSP, you’ve already paid thousands of dollars in unnecessary interest for that loan. Refinance your existing mortgage and you’ll overpay thousands again. What is YSP? Read on to learn about the mortgage industry’s dirty little secret and what you can do to avoid overpaying when mortgage refinancing.

Tags

Links

Just Answers - Environment - Capping-and-Trading Carbon Credits - Why Stop There?

Related Articles: